The global whole genome amplification (WGA) market is set for robust growth, with its valuation expected to increase from USD 2.9 million in 2024 to over USD 6.5 million by 2034, at a CAGR of 8.1% during the forecast period. This surge is driven by the rising demand for comprehensive genetic data collection and mapping of the human genome.
Whole genome amplification techniques have gained significant attention as researchers and healthcare providers increasingly focus on personalized medicine, genetic diagnostics, and the identification of novel biomarkers. The method of whole-cell genome amplification is becoming a pivotal tool for applications in oncology, genetic research, and developmental biology.
Market expansion is also supported by growing awareness and educational initiatives highlighting the utility and benefits of WGA technology. These efforts are fostering its adoption across research institutions, biotechnology firms, and healthcare settings, creating a conducive environment for market growth.
Grab Your Complete Report Instantly – https://www.futuremarketinsights.com/reports/whole-genome-amplification-market
Key Takeaways:
- Market Growth: The WGA market is projected to grow from USD 2.9 million in 2024 to USD 6.5 million by 2034, at a CAGR of 8.1%.
- Rising Demand: Increasing focus on genetic data collection and genome mapping is a key driver of demand for WGA technology.
- Applications in Research: WGA plays a critical role in oncology, genetic diagnostics, and personalized medicine, contributing to its widespread adoption.
- Awareness Initiatives: Efforts to educate and inform stakeholders about the advantages of WGA are unlocking new growth opportunities.
The whole genome amplification market is poised to make a substantial impact on advancing genetic research, paving the way for breakthroughs in healthcare and biotechnology.
Growth Drivers
- Increasing Demand for Genetic Data: The rising need for genetic data collection to identify and map genes in the human genome is driving the demand for whole genome amplification techniques.
- Awareness and Initiatives: There is a growing awareness of WGA methods, supported by initiatives aimed at educating the scientific community about their benefits, which is expected to create lucrative opportunities in the market.
- Government Support and Funding: Increased government backing for genomic research and initiatives aimed at enhancing healthcare infrastructure are contributing to market growth.
- Technological Advancements: Innovations in WGA techniques are improving reliability and efficiency, making these methods more appealing for various applications in genomics and molecular diagnostics.
Applications
Whole genome amplification is increasingly used in various fields, including:
- Genomic Research: For mapping and identifying genes.
- Disease Diagnosis: Enhancing the accuracy of genetic testing.
- Agricultural and Veterinary Applications: Improving genetic analysis in crops and livestock.
Regional Insights
- The market is expected to see significant growth in regions such as North America, where a strong focus on research and development exists.
- Asia-Pacific, particularly countries like India and China, is projected to experience rapid growth due to increasing investments in healthcare and genomics research.
Competition Outlook
The whole genome amplification market is poised to experience notable growth in the near future, owing to several factors. One of the main aspects of the dynamic growth is the increasing number of collaborations and partnerships between operating firms, leading to heightened market competition.
The demand for whole genome amplification is anticipated to develop due to the proliferation of product portfolios and strategic initiatives such as mergers and acquisitions, licensing, and partnerships. Such major mergers and acquisitions have further fuelled the growth of the market, contributing to the comprehensive expansion.
For instance
- In April 2024, Takara Bio USA pitched the Shasta Single-Cell System, an automated, high-throughput NGS solution for oncology research, enabling novel biomarker discovery and saving time and costs for researchers.
- In March 2024, BioSkryb Genomics launched ResolveDNA Whole Genome and ResolveOME Whole Genome and Transcriptome Single-Cell Core Kits, utilizing primary template-directed amplification for high-resolution single-cell DNA insights.
Leading Whole Genome Amplification Brands
- GE Healthcare
- Sygnis AG
- Illumina, Inc.
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Eurofins Scientific
- Agilent Technologies, Inc.
- Oxford Nanopore Technologies
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
Key Segments of Market Report
By Product Type:
As per product type, the industry has been segmented into single-cell WGA kits, complete WGA kits, WGA re-amplification kits, WGA and chip DNA kits, and others.
By Application:
The segment is branched into applications for drug discovery and development, disease diagnosis, agriculture, veterinary research, forensics, and others.
By End User:
Pharma and biotech companies, hospitals and clinics, contract research organizations, research and academic institutes, and others mainly utilize the sector.
By Region:
Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube